November 29, 2018
Daiichi Sankyo said on November 27 that it has agreed with Swiss giant Roche to collaborate on the development of a new HER2 low companion diagnostic for its investigational HER2-targeting antibody drug conjugate (ADC) DS-8201. Under the deal, Roche will...read more